Vital Therapies to sell 2.5 million common shares in public offering

BofA Merrill Lynch, Craig-Blair, Canaccord Genuity, SunTrust assist

By Devika Patel

Knoxville, Tenn., Sept. 30 – Vital Therapies, Inc. will sell 2.5 million common shares in its public sale with a 30-day greenshoe of 375,000 additional shares, according to a Form S-1/A filed Tuesday with the Securities and Exchange Commission. The deal was announced Sept. 22.

BofA Merrill Lynch is the bookrunning manager, and William Blair, Canaccord Genuity and SunTrust Robinson Humphrey Inc. are the co-managers.

Proceeds will be used for clinical development of the ELAD System, working capital and other general corporate purposes.

The biotherapeutic company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.